• Posted: January 26, 2018 MMRC Clinical Trials Highlights

    The MMRC has conducted 76 clinical trials, 24 of which are currently ongoing. Below are highlights and information about three of these exciting trials.

    READ MORE
  • Posted: January 23, 2018 MMRF Cancer Fighter

    We feel fortunate to have so many remarkable colleagues here at the MMRF. We want you to get to know some of these people too — what they do and why they...

    READ MORE
  • Posted: December 18, 2017 Patient-Powered Precision

    A must-read interview with our Founder Kathy Giusti, as she discusses the Harvard Business School Kraft Accelerator program and how it is working across all...

    READ MORE
  • Posted: December 12, 2017 ASH 2017 - Day Four

    Another ASH meeting has come to a close, but not without another exciting development in MM! This morning’s late-breaking abstract session (abstracts that...

    READ MORE
  • Posted: December 11, 2017 ASH 2017 - Day Three

    Dr. James Kochenderfer from the NIH presented the latest data on the anti-B-cell maturation antigen (BCMA) CAR-T cell therapy bb2121 (ABSTRACT 740). In his...

    READ MORE
  • Posted: December 10, 2017 ASH 2017 - Day Two

    Three more abstracts from this morning’s sessions used the MMRF’s CoMMpass data! Gene expression patterns are identified (Abstract 325) and new genes...

    READ MORE
  • Posted: December 9, 2017 ASH 2017 - Day One

    Two key abstracts were included in this morning’s myeloma session that used data from the MMRF CoMMpass Study to expand our understanding of myeloma...

    READ MORE
  • Posted: December 8, 2017 MMRF Recognizes Three Outstanding Organizations at 59th ASH Annual Meeting

    The Multiple Myeloma Research Foundation (MMRF) announced at the 59th ASH Annual Meeting the recipients of its awards for outstanding acceleration, innovation...

    READ MORE
  • Posted: December 8, 2017 MMRF Precision Medicine Model Drives New Discoveries in Multiple Myeloma

    The Multiple Myeloma Research Foundation (MMRF) today announced new discoveries driven by its precision medicine model into the disease drivers, patient...

    READ MORE
  • Posted: October 19, 2017 Why You Should Have Your Multiple Myeloma Genome Sequenced

    READ MORE

Page 1/15